The bile acids are a set of acidic steroids made from cholesterol in the liver. They serve several important physiologic functions. Their formation is the principal mechanism for cholesterol degradation; their secretion in bile is a major driving force for bile water formation; their detergency solubilizes bile lipids and the products of lipolysis in the gut. At the same time, bile acids are potentially toxic substances; toxic effects of bile acids are especially evident when they accumulate in excess in patients with cholestasis. The capacity of individual bile acids to subserve these functions and to produce toxicity is affected by their physical chemical properties; specifically, correlations with function and toxicity have been made with bile acid hydrophilicity-hydrophobicity. The hydrophobic-hydrophilic balance is maintained in part through the process of bile acid synthesis. In addition, however, the balance is maintained by post-synthetic mechanisms, ie. mechanisms of bile acid biotransformation. An understanding of these processes is importance not only in relation to bile acids, but also as a model of the biotransformation of other endo- and of xenobiotics. The set of bile acids is diverse. In addition to the conventional bile acids found in the bile of normal individuals, atypical bile acids of conventional size (eg. bile acids with a hydroxyl group in the six position of the steroid ring), short-chain bile acids, and other bile acid sub-sets have been defined. Certain of these, while present in only minute amounts in the normal individual, accumulate in excess in patients with cholestasis. Moreover, while bile acid conjugation with amino acids has been a well explored metabolic pathway, bile acid hydroxylation, sulfation, glucuronidation have been examined only preliminarily. Much of this work has been performed during the recent past in this laboratory. It is now proposed to pursue experimental directions opened to us by our previous studies. For these experiments the wide range of bile acids and bile acid conjugates synthesized, purified and characterized during the preceding grant period will be employed. Work performed on the enzymology of Phase I and II reactions of bile acids will be amplified. Enzymes involved in bile acid biotransformations will be identified, isolated, and characterized. Several of these will be cloned and expressed. The developmental pattern, induction, and polymorphic expression of certain of these enzymes will be defined. Finally, the structural association of Phase I and 11 mechanisms will be explored. On the basis of these studies it may ultimately be possible to develop therapeutic strategies for the manipulation of bile acids and other endobiotics in patients with liver disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK045123-01
Application #
3246687
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1992-05-01
Project End
1997-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Gardner-Stephen, Dione; Heydel, Jean-Marie; Goyal, Amit et al. (2004) Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos 32:340-7
Antonio, Laurence; Xu, Jing; Little, Joanna M et al. (2003) Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7. Arch Biochem Biophys 411:251-61
Radominska-Pandya, Anna; Chen, Guangping (2002) Photoaffinity labeling of human retinoid X receptor beta (RXRbeta) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRbeta. Biochemistry 41:4883-90
Radominska-Pandya, A; Chen, G; Samokyszyn, V M et al. (2001) Application of photoaffinity labeling with [(3)H] all trans- and 9-cis-retinoic acids for characterization of cellular retinoic acid--binding proteins I and II. Protein Sci 10:200-11
Jude, A R; Little, J M; Czernik, P J et al. (2001) Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved. Arch Biochem Biophys 389:176-86
Jude, A R; Little, J M; Freeman, J P et al. (2000) Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases. Arch Biochem Biophys 380:294-302
Samokyszyn, V M; Gall, W E; Zawada, G et al. (2000) 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 275:6908-14
Little, J M; Lester, R; Kuipers, F et al. (1999) Variability of human hepatic UDP-glucuronosyltransferase activity. Acta Biochim Pol 46:351-63
Senay, C; Battaglia, E; Chen, G et al. (1999) Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin. Arch Biochem Biophys 368:75-84
Gall, W E; Zawada, G; Mojarrabi, B et al. (1999) Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70:101-8

Showing the most recent 10 out of 18 publications